M. Reed

A Quantitative Systems Pharmacology Platform to Investigate the Impact of Alirocumab and Cholesterol-Lowering Therapies on Lipid Profiles and Plaque Characteristics

Christina M. Friedrich, W. Sasiela, J. Barrett, 2017, Gene regulation and systems biology.

Higher naloxone dosing in a quantitative systems pharmacology model that predicts naloxone-fentanyl competition at the opioid mu receptor level

Christina M. Friedrich, R. Moss, D. Carlo, 2020, PloS one.

A quantitative systems pharmacology (QSP) model to assess the action of blinatumomab in NHL patients (pts).

T. Yuraszeck, D. Bartlett, I. Singh, 2016 .

From Cold to Hot: Changing Perceptions and Future Opportunities for Quantitative Systems Pharmacology Modeling in Cancer Immunotherapy

Aman P. Singh, D. Bottino, Y. Lien, 2022, Clinical pharmacology and therapeutics.

Brief Report: Higher Fentanyl Exposures Require Higher Doses of Naloxone for Successful Reversals in a Quantitative Systems Pharmacology Model

Christina M. Friedrich, K. Kudrycki, M. Reed, 2022, Addiction Research and Adolescent Behaviour.

Virtual Systems Pharmacology (ViSP) software for simulation from mechanistic systems-level models

Albert Wang, Rebecca Baillie, Peter Forster, 2014, Front. Pharmacol..